126 related articles for article (PubMed ID: 25625726)
1. [Prostate cancer--new guidelines and the first care program].
Bratt O; Damber JE; Aldehag A; Brändström H
Lakartidningen; 2015 Jan; 112():. PubMed ID: 25625726
[TBL] [Abstract][Full Text] [Related]
2. [The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men].
Bratt O; Damber JE; Kärvinge C; Malm T; Hensjö LO; Hyttsten E
Lakartidningen; 2008 Feb 20-26; 105(8):524-8. PubMed ID: 18363292
[No Abstract] [Full Text] [Related]
3. Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, Despite no recommendations for PSA screening: results from a population-based study, 2003-2011.
Nordström T; Aly M; Clements MS; Weibull CE; Adolfsson J; Grönberg H
Eur Urol; 2013 Mar; 63(3):419-25. PubMed ID: 23083803
[TBL] [Abstract][Full Text] [Related]
4. Screening for prostate cancer: the current evidence and guidelines controversy.
Gomella LG; Liu XS; Trabulsi EJ; Kelly WK; Myers R; Showalter T; Dicker A; Wender R
Can J Urol; 2011 Oct; 18(5):5875-83. PubMed ID: 22018148
[TBL] [Abstract][Full Text] [Related]
5. [Large part of Swedish men PSA tested for early prostatic cancer. Few aware of the disadvantages of the test].
Bratt O; Grenabo L
Lakartidningen; 2010 Feb 17-23; 107(7):432-5. PubMed ID: 20384075
[No Abstract] [Full Text] [Related]
6. Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden.
Bratt O; Berglund A; Adolfsson J; Johansson JE; Törnblom M; Stattin P;
Scand J Urol Nephrol; 2010 Dec; 44(6):384-90. PubMed ID: 20624113
[TBL] [Abstract][Full Text] [Related]
7. [Early detection of cancer of the prostate. Pros and cons].
Hoesl CE; Altwein JE
MMW Fortschr Med; 2005 Apr; 147(14):32, 34-6. PubMed ID: 15887681
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
Black A; Berg CD
Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
[TBL] [Abstract][Full Text] [Related]
9. Prostate specific antigen best practice statement: 2009 update.
Greene KL; Albertsen PC; Babaian RJ; Carter HB; Gann PH; Han M; Kuban DA; Sartor AO; Stanford JL; Zietman A; Carroll P
J Urol; 2009 Nov; 182(5):2232-41. PubMed ID: 19781717
[TBL] [Abstract][Full Text] [Related]
10. Non-systematic screening for prostate cancer in Sweden--survey from the National Prostate Cancer Registry.
Stattin P; Johansson R; Damber JE; Hellström M; Hugosson J; Lundgren R; Varenhorst E; Johansson JE
Scand J Urol Nephrol; 2003; 37(6):461-5. PubMed ID: 14675917
[TBL] [Abstract][Full Text] [Related]
11. Discrepancies between guidelines and clinical practice regarding prostate-specific antigen testing.
Hamoen EH; Reukers DF; Numans ME; Barentsz JO; Witjes JA; Rovers MM
Fam Pract; 2013 Dec; 30(6):648-54. PubMed ID: 24107269
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.
Ito K
Int J Urol; 2009 May; 16(5):458-64. PubMed ID: 19341365
[TBL] [Abstract][Full Text] [Related]
14. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2012 Jul; 157(2):120-34. PubMed ID: 22801674
[TBL] [Abstract][Full Text] [Related]
15. Population-based study of prostate-specific antigen testing and prostate cancer detection in clinical practice in northern Sweden.
Pilebro B; Johansson R; Damber L; Damber JE; Stattin P
Scand J Urol Nephrol; 2003; 37(3):210-2. PubMed ID: 12775278
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer: measuring PSA.
Pezaro C; Woo HH; Davis ID
Intern Med J; 2014 May; 44(5):433-40. PubMed ID: 24816306
[TBL] [Abstract][Full Text] [Related]
17. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.
Cohn JA; Wang CE; Lakeman JC; Silverstein JC; Brendler CB; Novakovic KR; McGuire MS; Helfand BT
Urol Oncol; 2014 Jan; 32(1):41.e23-30. PubMed ID: 23911680
[TBL] [Abstract][Full Text] [Related]
18. [Prostate cancer units – hubs in the future care of men with prostate cancer].
Bratt O; Ahlgren G; Börjedahl AC; Franck-Lissbrant I; Waller C
Lakartidningen; 2017 Jan; 114():. PubMed ID: 28170061
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians.
Kell JS
Can J Urol; 2010 Feb; 17 Suppl 1():18-25. PubMed ID: 20170597
[TBL] [Abstract][Full Text] [Related]
20. [Focus on the screening for prostate cancer by PSA].
Roumeguère T; Van Velthoven R
Rev Med Brux; 2013 Sep; 34(4):311-9. PubMed ID: 24195246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]